Dr. Sarah Prinsloo Ph.D., M.A., LMFT-S, LPC, BCN-L, enjoyed a 15 year career as a faculty member and applied neuroscientist at The University of Texas MD Anderson Cancer Center.  She had dual appointments in the Faculty of Neurosurgery and the Faculty of Palliative, Rehabilitation, and Integrative Medicine.

Her research has focused on pain and cancer-related symptom management.  Some of her work looked at brain activity to developing neuromodulation protocols for alleviating Chemotherapy Induced Peripheral Neuropathy.
​​
She is now on a mission to accelerate implementation of that research and bring the latest non-pharmaceutical therapies to cancer survivors. She is founder of a collaborative project provide clinical services while also continuing to enhance the research findings.